Celon PharmaWAR:CLN -0.10%48 Days Inventory is 135.96 as of Mar. 2026, which is 46% below its 10-year median of 252.12. GuruFocus rates WAR:CLN with a GF Score™ of 48/100 and a GF Value™ of zł23.11 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 919 Drug Manufacturers companies, Celon Pharma ranks worse than 56.15% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Celon Pharma's Average Total Inventories for the
three
months ended in Mar. 2026 was zł24.9 Mil. Celon Pharma's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł16.7 Mil.
Hence, Celon Pharma's Days Inventory for the
three
months ended in Mar. 2026 was 135.96.
The historical rank and industry rank for Celon Pharma's Days Inventory or its related term are showing as below:
WAR:CLN'
s Days Inventory Range Over the Past 10 Years
Min: 148.77 Med: 252.12 Max: 419.38
Current: 178.95
During the past 11 years, Celon Pharma's highest Days Inventory was 419.38. The lowest was 148.77. And the median was 252.12.
WAR:CLN's Days Inventory is ranked worse than 56.15% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs WAR:CLN: 178.95
Celon Pharma's Days Inventory
declined
from Mar. 2025 (144.38) to Mar. 2026 (135.96).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Celon Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Celon Pharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.44.
Celon Pharma (WAR:CLN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Celon Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Celon Pharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Celon Pharma Days Inventory Related Terms
Celon Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Celon Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:CLN vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Celon Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Celon Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Celon Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Celon Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celon Pharma (WAR:CLN) has a Days Inventory of 135.96 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Celon Pharma and its competitors. This is 46% below median its historical median of 252.12. Over the past decade, Celon Pharma's Days Inventory has ranged from 148.77 to 419.38. According to the industry distribution chart, Celon Pharma ranks #516 out of 919 companies in the Drug Manufacturers industry, placing it in the top 56.1%.
Is Celon Pharma's Days Inventory too high?
Celon Pharma's current Days Inventory of 135.96 is 46% below median its 10-year median of 252.12. Over the past 10 years, this metric has ranged from a low of 148.77 to a high of 419.38. The Drug Manufacturers industry median Days Inventory is 164.48. Celon Pharma's value of 135.96 is 17.3% below this industry median. Based on the distribution chart, Celon Pharma ranks #516 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Celon Pharma has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Celon Pharma's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Celon Pharma ranks #516 out of 919 companies for Days Inventory. This places Celon Pharma in the lower half of its industry. The industry median Days Inventory is 164.48. Celon Pharma's value of 135.96 is 17.3% below this benchmark. Historically, Celon Pharma's own Days Inventory has ranged from 148.77 to 419.38 over the past decade. While the company's 10-year median is 252.12 vs. the industry median of 164.48, Celon Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Celon Pharma's current Days Inventory of 135.96 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Celon Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Celon Pharma's current Days Inventory is 135.96, which is 46% below median its own 10-year median of 252.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celon Pharma stock overvalued right now?
Based on GuruFocus' analysis, Celon Pharma (WAR:CLN) is currently considered Modestly Undervalued. The stock's GF Value™ is zł23.11, compared to a current price of zł19.78 — trading 14.4% below its estimated fair value. The current Days Inventory is 135.96, which is 46% below median its 10-year median of 252.12 and 17.3% below the Drug Manufacturers industry median of 164.48. Celon Pharma's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Celon Pharma (WAR:CLN), the current Days Inventory is 135.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Celon Pharma (WAR:CLN) Overvalued in 2026?
Based on GuruFocus' analysis, Celon Pharma stock appears to be undervalued.
The current stock price of zł19.78 is trading 14.4% below its estimated GF Value™ of zł23.11.
GuruFocus considers Celon Pharma to be Modestly Undervalued.
Key valuation signals for WAR:CLN:
Days Inventory: 135.96 (46% below median its 10-year median of 252.12)
GF Value™: zł23.11 vs. price of zł19.78 (14.4% below fair value)
Industry Position: 17.3% below the Drug Manufacturers median (#516 of 919)
No single metric tells the full story. See the WAR:CLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.
48GF Score
Get the complete analysis for WAR:CLN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CLN has been successfully added to your 
